Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Nonmedical use of tapentadol immediate release by college students.

Dart RC, Bartelson BB, Adams EH.

Clin J Pain. 2014 Aug;30(8):685-92. doi: 10.1097/AJP.0000000000000001.

PMID:
24042351
2.

Assessment of the abuse of tapentadol immediate release: the first 24 months.

Dart RC, Cicero TJ, Surratt HL, Rosenblum A, Bartelson BB, Adams EH.

J Opioid Manag. 2012 Nov-Dec;8(6):395-402. doi: 10.5055/jom.2012.0139.

PMID:
23264317
3.

Dose conversion between tapentadol immediate and extended release for low back pain.

Etropolski MS, Okamoto A, Shapiro DY, Rauschkolb C.

Pain Physician. 2010 Jan-Feb;13(1):61-70.

4.

Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.

Biondi D, Xiang J, Benson C, Etropolski M, Moskovitz B, Rauschkolb C.

Pain Physician. 2013 May-Jun;16(3):E237-46.

5.

Diversion and Illicit Sale of Extended Release Tapentadol in the United States.

Dart RC, Surratt HL, Le Lait MC, Stivers Y, Bebarta VS, Freifeld CC, Brownstein JS, Burke JJ, Kurtz SP, Dasgupta N.

Pain Med. 2016 Aug;17(8):1490-6. doi: 10.1093/pm/pnv032. Epub 2015 Dec 14.

6.

Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots.

McCabe SE, West BT, Teter CJ, Boyd CJ.

Addict Behav. 2014 Jul;39(7):1176-82. doi: 10.1016/j.addbeh.2014.03.008. Epub 2014 Mar 12.

7.

The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery .

Stegmann JU, Weber H, Steup A, Okamoto A, Upmalis D, Daniels S.

Curr Med Res Opin. 2008 Nov;24(11):3185-96. doi: 10.1185/03007990802448056 . Epub 2008 Oct 15.

PMID:
18851776
9.

Medical and nonmedical users of prescription drugs among college students.

Rozenbroek K, Rothstein WG.

J Am Coll Health. 2011;59(5):358-63. doi: 10.1080/07448481.2010.512044.

PMID:
21500053
10.

Nonmedical use of opioid analgesics among Ontario students.

Brands B, Paglia-Boak A, Sproule BA, Leslie K, Adlaf EM.

Can Fam Physician. 2010 Mar;56(3):256-62.

11.

Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain.

Kwong WJ, Hammond G, Upmalis D, Okamoto A, Yang M, Kavanagh S.

Clin J Pain. 2013 Aug;29(8):664-72. doi: 10.1097/AJP.0b013e318274b695.

PMID:
23835764
12.

Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride.

Etropolski M, Kelly K, Okamoto A, Rauschkolb C.

Adv Ther. 2011 May;28(5):401-17. doi: 10.1007/s12325-011-0018-0. Epub 2011 Apr 13.

PMID:
21494892
13.

Motives for nonmedical use of prescription opioids among high school seniors in the United States: self-treatment and beyond.

McCabe SE, Boyd CJ, Cranford JA, Teter CJ.

Arch Pediatr Adolesc Med. 2009 Aug;163(8):739-44. doi: 10.1001/archpediatrics.2009.120.

14.

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.

Daniels S, Casson E, Stegmann JU, Oh C, Okamoto A, Rauschkolb C, Upmalis D.

Curr Med Res Opin. 2009 Jun;25(6):1551-61. doi: 10.1185/03007990902952825. Erratum in: Curr Med Res Opin. 2009 Jun;25(6):1561. Dosage error in article text.

PMID:
19445652
15.

Tapentadol immediate release for the relief of moderate-to-severe acute pain.

Hartrick CT.

Expert Opin Pharmacother. 2009 Nov;10(16):2687-96. doi: 10.1517/14656560903313734. Review. Erratum in: Expert Opin Pharmacother. 2010 Jan;11(1):167.

PMID:
19795998
16.

Population pharmacokinetics of tapentadol immediate release (IR) in healthy subjects and patients with moderate or severe pain.

Xu XS, Smit JW, Lin R, Stuyckens K, Terlinden R, Nandy P.

Clin Pharmacokinet. 2010 Oct;49(10):671-82. doi: 10.2165/11535390-000000000-00000.

PMID:
20818833
17.

Tapentadol abuse potential: a postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment.

Butler SF, McNaughton EC, Black RA.

Pain Med. 2015 Jan;16(1):119-30. doi: 10.1111/pme.12524. Epub 2014 Sep 22.

PMID:
25243972
18.

Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis pain.

Vorsanger G, Xiang J, Okamoto A, Upmalis D, Moskovitz B.

J Opioid Manag. 2010 May-Jun;6(3):169-79.

PMID:
20642246
19.

Immediate-release tapentadol or oxycodone for treatment of acute postoperative pain after elective arthroscopic shoulder surgery: a randomized, phase IIIb study.

Vorsanger GJ, Klopfer AM, Xiang J, Benson CJ, Moskovitz BL, Rosenthal NR.

J Opioid Manag. 2013 Jul-Aug;9(4):281-90. doi: 10.5055/jom.2013.0170.

PMID:
24353022
20.

Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.

Hale M, Upmalis D, Okamoto A, Lange C, Rauschkolb C.

Curr Med Res Opin. 2009 May;25(5):1095-104. doi: 10.1185/03007990902816970 .

PMID:
19301989

Supplemental Content

Support Center